Journal of Peking University(Health Sciences) >
Analysis of risk factors influencing the detection rate of urate crystal by dual energy computed tomography
Received date: 2019-08-28
Online published: 2021-04-21
Objective: To explore the risk factors of detection of uric acid crystals by dual energy CT (DECT) in patients with gout diagnosed by gold standard. Methods: From June 2011 to December 2018, clinical data of 29 patients were collected who were diagnosed with acute or chronic gout by positive polarized light analysis of joint synovial fluid in First Hospital of Peking University. Chi-square test, Logistic regression and t-test were used. The relationship between DECT and the clinical data, laboratory examination and drug treatment were analyzed. Results: In this study, 29 patients were included, of whom, 22 patients were detected with uric acid crystals by DECT, and 7 patients were not. According to whether the uric acid crystals were detected or not by DECT, the patients were divided into two groups. Compared with the negative group,the patients were older in positive group [(47±12) vs. (39±11) years, P=0.15], had higher body bass index (BMI) [(27.9±3.7) vs. (22.8±2.1) kg/m2, P=0.002], longer gout disease duration [(135±102) vs.(45±53) months, P=0.035], higher in the highest serum uric acid in history [(643±121) vs. (543±103) μmol/L, P=0.043]. Although uric acid near DECT in positive group was higher than in negative group, there was no statistical difference [(558±150) vs. (513±89) μmol/L, P=0.497]. Comparing positive group with negative group, the percentage of the patients in acute phase was higher than in chronic phase [18(81.8%) vs. 4(57%), P=0.311];the percentage of the patients taking uric-acid-lowering drugs was higher than the other group [22(100%) vs. 5 (71%), P=0.052];the percentage of the patients with recurrent typical attacks was higher than that of those without typical attacks [22 (100%) vs.6 (85%), P=0.241]. The consistency of symptoms and the finding of uric acid crystals by DECT had been compared between the joints. The right knee joint had the highest consistency (Kappa=0.627), followed by the left MTP1 (Kappa=0.58), the right metatarsophalangeal 1(MTP1, Kappa=0.551) and the left knee (Kappa=0.494), all of which had statistical significance. The consistency of the ankle joint was lower (the right ankle joint: Kappa=0.19, the left ankle joint: Kappa=0.256), showing no statistical significance. BMI (kg/m2) [2.307 (1.139-4.670), P=0.02], gout duration (years) [0.306 (0.906-4.881), P=0.186], and the highest uric acid level in history (mg/dL) [0.023 (0.981-2.764), P=0.137] had relationship to the positive result of urate crystals in DECT. Conclusion: Gout patients with larger BMI, higher previous highest uric acid value and longer gout duration had higher sensitivity of the positive result in DECT.
Key words: Gout; Dual-energy CT; Urate crystal; Sensitivity
Yi-fan XIE , Yu WANG , Xue-rong DENG , Yan GENG , Lan-lan JI , Zhuo-li ZHANG . Analysis of risk factors influencing the detection rate of urate crystal by dual energy computed tomography[J]. Journal of Peking University(Health Sciences), 2021 , 53(2) : 261 -265 . DOI: 10.19723/j.issn.1671-167X.2021.02.005
| [1] | Roddy E, Choi HK. Epidemiology of gout[J]. Rheum Dis Clin North Am, 2014,40(2):155-175. |
| [2] | 邓雪蓉, 王昱, 张卓莉. 新型影像学技术在痛风诊治中的应用进展[J]. 中国实用内科杂志, 2018,38(12):1119-1122. |
| [3] | Wang Y, Deng X, Xu Y, et al. Detection of uric acid crystal deposition by ultrasonography and dual-energy computed tomography: A cross-sectional study in patients with clinically diagnosed gout[J]. Medicine (Baltimore), 2018,97(42):e12834. |
| [4] | Ogdie A, Taylor WJ, Weatherall M, et al. Imaging modalities for the classification of gout: systematic literature review and meta-analysis[J]. Ann Rheum Dis, 2015,74(10):1868-1874. |
| [5] | Choi HK, Burns LC, Shojania K, et al. Dual energy CT in gout: a prospective validation study[J]. Ann Rheum Dis, 2012,71(9):1466-1471. |
| [6] | Sun C, Qi X, Tian Y, et al. Risk factors for the formation of double-contour sign and tophi in gout[J]. J Orthop Surg Res, 2019,14(1):239. |
| [7] | Loeb JN. The influence of temperature on the solubility of monosodium urate[J]. Arthritis Rheum, 1972,15(2):189-192. |
| [8] | Horvath SM, Hollander JL. Intra-articular temperature as a measure of joint reaction[J]. J Clin Invest, 1949,28(3):469-473. |
| [9] | Fiddis RW, VlachosL N, Calvert PD. Studies of urate crystallisation in relation to gout[J]. Ann Rheum Dis, 1983,42(Suppl 1):5-12. |
| [10] | Tak HK, Cooper SM, Wilcox WR. Studies on the nucleation of monosodium urate at 37 degrees c[J]. Arthritis Rheum, 1980,23(5):574-580. |
| [11] | Perez-Ruiz F, Calabozo M, Pijoan JI, et al. Effect of urate-lowering therapy on the velocity of size reduction of tophi in chronic gout[J]. Arthritis Rheum, 2002,47(4):356-360. |
| [12] | Becker MA, Schumacher HR Jr, Wortmann RL, et al. Febuxostat compared with allopurinol in patients with hyperuricemia and gout[J]. N Engl J Med, 2005,353(23):2450-2461. |
| [13] | Ellmann H, Bayat S, Araujo E, et al. Effects of conventional uric acid lowering therapy on monosodium urate crystal deposits[J]. Arthritis Rheum, 2020,72(1):150-156. |
| [14] | Wilcox WR, Khalaf AA. Nucleation of monosodium urate crystals[J]. Ann Rheum Dis, 1975,34(4):332-339. |
| [15] | Simkin PA. The pathogenesis of podagra[J]. Ann Intern Med, 1977,86(2):230-233. |
| [16] | Zhang W, Jin Z, Xiang W, et al. Ultrasonographic features of lower-limb joints in gout: which joints and clinical characteristics would provide more information for diagnosis[J]. J Clin Rheum, 2020,26(1):14-18. |
| [17] | Dalbeth N, House ME, Aati O, et al. Urate crystal deposition in asymptomatic hyperuricaemia and symptomatic gout: a dual energy CT study[J]. Ann Rheum Dis, 2015,74(5):908-911. |
| [18] | Allen DJ, Milosovich G, Mattocks AM. Inhibition of monosodium urate needle crystal growth[J]. Arthritis Rheum, 1965,8(6):1123-1133. |
/
| 〈 |
|
〉 |